LOAMU
EVH icon

Lombard Odier Asset Management (USA)’s Evolent Health EVH Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-535,100
Closed -$3.85M – 254
2019
Q3 		$3.85M Buy
535,100
+335,100
+168% +$2.4M 0.37% 85
2019
Q2 		$1.59M Buy
+200,000
New +$2.37M 0.13% 151

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s EVH Position: Q4 2019 in Review

Lombard Odier Asset Management (USA) sold out of Evolent Health (EVH) in Q4 2019, closing a stake of 180,000 shares — an estimated $1.29M sold.

Lombard Odier Asset Management (USA) first reported a position in EVH in Q4 2016 and held it in 10 quarters. The position peaked at $7.04M in Q2 2019. 167 funds tracked by Wall St. Rank hold EVH as of Q4 2019.

  • Lombard Odier Asset Management (USA) reported no remaining Evolent Health position as of Q4 2019 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 180,000 Evolent Health shares in Q4 2019, an estimated $1.29M.
  • Lombard Odier Asset Management (USA) first reported a position in Evolent Health in Q4 2016 and held it in 10 quarters.
  • Lombard Odier Asset Management (USA)'s Evolent Health position peaked at $7.04M in Q2 2019.
  • 167 funds tracked by Wall St. Rank held Evolent Health as of Q4 2019.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2019, filed 14 Feb 2020.